School of Medicine

 

The foundation of the American Society of Clinical Oncology (ASCO) - Conquer Cancer, the ASCO Foundation, has named Aneesha Ananthula, MD, a Hematology-Oncology Fellow at LSU Health New Orleans School of Medicine, one of 164 recipients of the Conquer Cancer, the ASCO Foundation, 2021 ASCO Annual Meeting Merit Awards.

 

A limited number of Merit Awards are given to fellows/oncology trainees whose research is addressed in high-quality abstracts submitted to an ASCO Meeting and recognized for its scientific merit. These distinguished awards support oncology trainees who are first authors on abstracts selected for presentation at the ASCO Annual Meeting. These oncology professionals are recognized for their respective field and research advancements within the cancer care community.

 

The 2021 ASCO Annual Meeting will be an online-only experience, June 4-8, 2021.

 

Dr. Ananthula will present her research findings on the association and prevalence of venous thromboembolism in cancer patients with COVID. Venous thromboembolism (VTE) is a condition where a blood clot forms in a vein. There are two forms -- deep vein thrombosis (DVT) and pulmonary embolism (PE). Complications of VTE include long-term damage to the valves in the vein, as well as death.

 

The 2021 Conquer Cancer Merit Awards are sponsored by:

Anonymous, AbbVie, Inc., ASCO Employees, Association of Northern California Oncologists, AstraZeneca, BeiGene, Friends and Family of Dr. and Mrs. Ronald Beller, The Berry Family, Dr. and Mrs. Douglas W. Blayney, Breast Cancer Research Foundation®, Bristol Myers Squibb, Jonathan K. and Cora Y. Cho Charitable Fund, Michael Craig Cox, PharmD, MHS, BCOP, Eisai Inc., Estate of Darla C. Ellis, Epiphany Partners Inc., G1 Therapeutics, GlaxoSmithKline Oncology, Harborside, Friends, Colleagues, and Family of Joe Hogan, Ipsen Biopharmaceuticals Inc., Kimberly Irvine, Michael Kelley, MD & Elise Hoffman, PharmD, Nicole M. Kuderer, MD and Gary H. Lyman, MD, MPH, FASCO, Natasha B. Leighl, MD, FASCO, William G. Leonard and Victoria Wang, MD, PhD, William T. Leslie, MD, Lilly, Loxo Oncology Inc., a wholly owned subsidiary of Eli Lilly and Company, Therese Marie Mulvey, MD, FASCO, Friends and Family of Dr. James B. Nachman, New Rhein Healthcare, LLC, Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., Dr. Kathleen Pritchard Medicine Professional Corporation, Sarah Cannon Research Institute, Frances A. Shepherd, MD, FASCO, Stephen A. Sherwin, MD, Drs. Rachna and Puneet Shroff, Syndax Pharmaceuticals, Inc., Nizar M. Tannir, MD, Anthony and Marilyn Tolcher and Dr. Michael and Deborah Troner.